CompletedEarly Phase 1NCT03020524

Autologous CD4 T-Cells in HIV (C34-CXCR4)

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Pennsylvania
Principal Investigator
Pablo Tebas, MD, LMFT
University of Pennaylvania
Intervention
Autologous CD4 T-Cells(biological)
Enrollment
9 enrolled
Eligibility
18 years · All sexes
Timeline
20172020

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03020524 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency

← Back to all trials